Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial is conducted in China. This trial aims for a comparison of the effect on glycemic control in subjects with type 2 diabetes of insulin detemir or NPH-insulin given once daily at bedtime as add-on to oral anti-diabetic drug(s).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Detemir; Insulin, Globin Zinc; Insulin, Isophane; Isophane insulin, beef; Isophane Insulin, Human

Criteria

Inclusion Criteria:

• Type 2 diabetes

• HbA1C greater than 7.5% and less than or equal to 11.0%

• Currently on any oral antidiabetic drug (OAD) more than or equal to 3 months

Exclusion Criteria:

• Previous acute treatment with insulin for more than 7 days.

• Treatment with OAD(s) which does not adhere to the approval labeling.

• Proliferate retinopathy or maculopathy that has required acute treatment within the last year.

• Known hypoglycaemia unawareness or recurrent major hypoglycaemia, that may interfere with study participation as judged by the Investigator.